Oxidative modification of low-density lipoproteins and the inhibition of relaxations mediated by endothelium-derived nitric oxide in rabbit aorta
- PMID: 1596684
- PMCID: PMC1908615
- DOI: 10.1111/j.1476-5381.1992.tb14237.x
Oxidative modification of low-density lipoproteins and the inhibition of relaxations mediated by endothelium-derived nitric oxide in rabbit aorta
Abstract
1. The mechanism by which Cu(2+)-oxidized low-density lipoproteins (oxLDL) inhibit acetylcholine (ACh)-evoked relaxations mediated by endothelium-derived nitric oxide (EDRF) in rabbit aortic rings was investigated. The proposed role of lysophosphatidylcholine (LPC) in the inhibition was also studied. 2. The kinetics of lipid peroxidation of native low-density lipoproteins (LDL) from individual donors, as measured by changes in conjugated diene concentration, were related to the inhibitory effects of the resultant oxLDL. It was found that the more susceptible LDL was to oxidation, the greater the inhibition. 3. No correlation was found between the inhibitory effects of oxLDL and LPC content. 4. Synthetic 1-palmitoyl LPC produced an inhibition of ACh-induced relaxations and when added to precontracted rings evoked nitric oxide-mediated endothelium-dependent relaxation. This latter effect was not elicited by oxLDL. 5. Synthetic 1-palmitoyl (10 microM) had no effect on relaxations evoked by glyceryl trinitrate in endothelium-denuded aortic rings in contrast to the inhibition found previously for oxLDL. 6. Concentrations of oxLDL and phospholipase A2-treated LDL which inhibited relaxation contained very different LPC concentrations. Unlike oxLDL, the inhibitory effects of phospholipase A2-treated LDL preparations were independent of the donors and showed no lag period. 7. We suggest that there are differences in the mechanisms by which oxLDL and 1-palmitoyl LPC exert their inhibitory effects on relaxation. 8. The inhibition of relaxation by oxLDL (1-2 mg protein ml-1) was prevented by the presence of high-density lipoproteins (HDL; 1-2 mg protein ml-1).9. It is proposed that prevention of the inhibition of relaxation by HDL is consistent with the inhibitory factor(s) being lipophilic constituents of oxLDL. However, variations in the inhibitory effects of oxLDL preparations are not due to differences in their LPC content and factors other than LPC must contribute to the inhibition.
Similar articles
-
Native and oxidized low-density lipoproteins have different inhibitory effects on endothelium-derived relaxing factor in the rabbit aorta.Br J Pharmacol. 1990 May;100(1):21-6. doi: 10.1111/j.1476-5381.1990.tb12045.x. Br J Pharmacol. 1990. PMID: 2115388 Free PMC article.
-
High density lipoprotein reverses inhibitory effect of oxidized low density lipoprotein on endothelium-dependent arterial relaxation.Circ Res. 1993 May;72(5):1103-9. doi: 10.1161/01.res.72.5.1103. Circ Res. 1993. PMID: 8477522
-
Lysophosphatidylcholine inhibits relaxation of rabbit abdominal aorta mediated by endothelium-derived nitric oxide and endothelium-derived hyperpolarizing factor independent of protein kinase C activation.Arterioscler Thromb Vasc Biol. 1995 Dec;15(12):2290-7. doi: 10.1161/01.atv.15.12.2290. Arterioscler Thromb Vasc Biol. 1995. PMID: 7489255
-
The effects of native LDL and oxidized LDL on EDRF bioactivity and nitric oxide production in vascular endothelium.J Lab Clin Med. 1994 Nov;124(5):672-83. J Lab Clin Med. 1994. PMID: 7964125 Review.
-
The mechanisms of lysophosphatidylcholine in the development of diseases.Life Sci. 2020 Apr 15;247:117443. doi: 10.1016/j.lfs.2020.117443. Epub 2020 Feb 19. Life Sci. 2020. PMID: 32084434 Review.
Cited by
-
Coronary flow reserve.Br Heart J. 1993 Apr;69(4):279-81. doi: 10.1136/hrt.69.4.279. Br Heart J. 1993. PMID: 8489855 Free PMC article. No abstract available.
-
Lipids and endothelium-dependent vasodilation--a review.Lipids. 2002 Jan;37(1):1-15. doi: 10.1007/s11745-002-0858-6. Lipids. 2002. PMID: 11876256 Review.
-
Detrimental vascular effects of lysophosphatidylcholine is limited by other phospholipid components of low-density lipoprotein.Mol Cell Biochem. 2003 Aug;250(1-2):159-66. doi: 10.1023/a:1024913721398. Mol Cell Biochem. 2003. PMID: 12962154
-
Antioxidants, lipoprotein oxidation, and arterial function.Lipids. 1996 Mar;31 Suppl:S83-5. doi: 10.1007/BF02637056. Lipids. 1996. PMID: 8729099 Review.
-
Increased intracellular Ca2+ selectively suppresses IL-1-induced NO production by reducing iNOS mRNA stability.J Cell Biol. 1995 Jun;129(6):1651-7. doi: 10.1083/jcb.129.6.1651. J Cell Biol. 1995. PMID: 7540612 Free PMC article.
References
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Miscellaneous